GIA
COYA icon

GHP Investment Advisors’s Coya Therapeutics COYA Stock Holding History

GHP Investment Advisors’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$153K Hold
26,171
– – 0.01% 427
2026
Q1 		$103K Hold
26,171
– – ﹤0.01% 451
2025
Q4 		$152K Hold
26,171
– – 0.01% 411
2025
Q3 		$149K Hold
26,171
– – 0.01% 407
2025
Q2 		$150K Hold
26,171
– – 0.01% 400
2025
Q1 		$169K Hold
26,171
– – 0.01% 389
2024
Q4 		$150K Hold
26,171
– – 0.01% 398
2024
Q3 		$169K Buy
+26,171
New +$165K 0.01% 400

Other funds holding COYA

PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
BL
BFSG LLC Irvine, California $1.13B AUM 29.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

GHP Investment Advisors's COYA Position: Q2 2026 in Review

GHP Investment Advisors held its Coya Therapeutics (COYA) position steady in Q2 2026 at 26,171 shares worth $153K. The position accounts for 0.01% of the portfolio, ranked #427.

GHP Investment Advisors first reported a position in COYA in Q3 2024 and has held it in 8 quarters since. The position peaked at $169K in Q1 2025. 7 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • GHP Investment Advisors held 26,171 shares of Coya Therapeutics worth $153K as of Q2 2026.
  • GHP Investment Advisors left its Coya Therapeutics share count unchanged in Q2 2026.
  • Coya Therapeutics made up 0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #427 holding.
  • GHP Investment Advisors first reported a position in Coya Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • GHP Investment Advisors's Coya Therapeutics position peaked at $169K in Q1 2025.
  • 7 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.